(NAMS) NewAmsterdam Pharma - Performance -17.8% in 12m
Compare NAMS with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
41.54%
#12 in Group
Rel. Strength
31.10%
#5512 in Universe
Total Return 12m
-17.79%
#55 in Group
Total Return 5y
48.43%
#26 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -17.64%
(?) Percentile in Group
12m Total Return: NAMS (-17.8%) vs XBI (-12.1%)
5y Drawdown (Underwater) Chart
Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| ABBV NYSE AbbVie |
-19.2% | 9.47% | 151% | 75.1 | 14.6 | 0.38 | -49.6% | -19% |
| UTHR NASDAQ United Therapeutics |
-11.7% | 23% | 168% | 11.8 | 10.6 | 1.43 | 83.8% | 78.5% |
| HLN NYSE Haleon |
-1.45% | 26.1% | 39.7% | 24.7 | 20.3 | 1.8 | 27.1% | - |
| AMGN NASDAQ Amgen |
-10.9% | 9.64% | 39.3% | 38.4 | 14.1 | 0.99 | -18.8% | -20% |
| LONN SW Lonza |
-3.29% | 3.72% | 31.6% | 60.7 | 31.7 | 1.15 | 12.6% | -10.3% |
| BIM PA Biomerieux |
2.96% | 17.6% | 11.9% | 31.5 | 25.4 | 1.47 | -58.7% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
-10.2% | -24.7% | -1.51% | 29.1 | 20.7 | 0.27 | 61.5% | 31.6% |
| KMDA NASDAQ Kamada |
-6.62% | 33.3% | -5.06% | 24.3 | 22.8 | 0.91 | 47.7% | 3.93% |
Performance Comparison: NAMS vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for NAMS
| Total Return (including Dividends) | NAMS | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -31.32% | -14.90% | -7.04% |
| 3 Months | -31.55% | -14.51% | -10.88% |
| 12 Months | -17.79% | -12.11% | 5.72% |
| 5 Years | 48.43% | -20.56% | 100.77% |
| Trend Score (consistency of price movement) | NAMS | XBI | S&P 500 |
| 1 Month | -87.7% | -85.2% | -76.1% |
| 3 Months | -34.1% | -87.6% | -86.4% |
| 12 Months | 22.6% | -24% | 67.8% |
| 5 Years | 76.9% | -52.8% | 84.3% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
| 1 Month | #161 | -19.3% | -26.1% |
| 3 Month | #113 | -19.9% | -23.2% |
| 12 Month | #55 | -6.47% | -22.3% |
| 5 Years | #14 | 243% | 3.83% |
FAQs
Does NAMS NewAmsterdam Pharma outperforms the market?
No,
over the last 12 months NAMS made -17.79%, while its related Sector, the SPDR S&P Biotech (XBI) made -12.11%.
Over the last 3 months NAMS made -31.55%, while XBI made -14.51%.
Over the last 3 months NAMS made -31.55%, while XBI made -14.51%.
Performance Comparison NAMS vs Indeces and Sectors
NAMS vs. Indices NAMS is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 5.26% | -24.3% | -6.48% | -23.5% |
| US NASDAQ 100 | QQQ | 5.75% | -23.5% | -6.39% | -21.5% |
| US Dow Jones Industrial 30 | DIA | 3.36% | -26.2% | -8.45% | -24.5% |
| German DAX 40 | DAX | -7.24% | -23.3% | -25.1% | -37.1% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -1.74% | -23.6% | -11.3% | -25.7% |
| Hongkong Hang Seng | HSI | -2.41% | -20.2% | -7.87% | -33.9% |
| India NIFTY 50 | INDA | 1.25% | -34.7% | -5.90% | -18.5% |
| Brasil Bovespa | EWZ | 0.75% | -25.0% | -6.80% | -6.86% |
NAMS vs. Sectors NAMS is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 5.45% | -23.7% | -14.7% | -31.1% |
| Consumer Discretionary | XLY | 6.85% | -25.1% | -8.69% | -25.1% |
| Consumer Staples | XLP | - | -31.2% | -14.1% | -30.3% |
| Energy | XLE | 4.30% | -19.4% | -5.42% | -4.99% |
| Financial | XLF | 2.55% | -26.5% | -14.4% | -37.2% |
| Health Care | XLV | 2.85% | -24.5% | -5.29% | -17.7% |
| Industrial | XLI | 2.76% | -25.4% | -5.85% | -21.7% |
| Materials | XLB | 1.76% | -23.9% | 0.94% | -9.85% |
| Real Estate | XLRE | -0.49% | -26.3% | -6.20% | -32.2% |
| Technology | XLK | 5.95% | -21.5% | -0.45% | -14.6% |
| Utilities | XLU | -0.26% | -29.2% | -10.7% | -44.2% |
| Aerospace & Defense | XAR | 0.60% | -30.7% | -15.9% | -41.0% |
| Biotech | XBI | 0.74% | -16.4% | 9.42% | -5.68% |
| Homebuilder | XHB | 5.87% | -22.1% | 12.9% | -6.10% |
| Retail | XRT | 5.50% | -25.6% | 0.81% | -10.8% |